Hagenah J, Saunders-Pullman R, Hedrich K, Kabakci K, Habermann K, Wiegers K, Mohrmann K, Lohnau T, Raymond D, Vieregge P, Nygaard T, Ozelius L J, Bressman S B, Klein C
Department of Neurology, University of Lübeck, Lübeck, Germany.
Neurology. 2005 Mar 8;64(5):908-11. doi: 10.1212/01.WNL.0000152839.50258.A2.
Mutations in GTP cyclohydrolase I (GCHI) are found in 50 to 60% of cases with dopa-responsive dystonia (DRD). Heterozygous GCHI exon deletions, undetectable by sequencing, have recently been described in three DRD families. We tested 23 individuals with DRD for the different mutation types by conventional and quantitative PCR analyses and found mutations, including two large exon deletions, in 87%. The authors attribute this high mutation rate to rigorous inclusion criteria and comprehensive mutational analysis.
50%至60%的多巴反应性肌张力障碍(DRD)病例中可发现鸟苷三磷酸环化水解酶I(GCHI)突变。最近在三个DRD家族中描述了通过测序无法检测到的杂合性GCHI外显子缺失。我们通过常规和定量PCR分析对23名DRD患者进行了不同突变类型的检测,发现87%的患者存在突变,包括两个大的外显子缺失。作者将这种高突变率归因于严格的纳入标准和全面的突变分析。